ACE and COVID-19: The COVID-RASi Trial (NCT04-591210): An international randomized clinical trial aimed at assessing the potential benefits of angiotensin modulators (Angiotensin converting enzyme inhibitor and Angiotensin II Receptor Blockers) on clinical outcomes in COVID-19 patients.